Biotechnology
NGNE
22.64
price up icon2.56%   0.565
 

Neurogene Inc (NGNE)
full-star
loading
Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Neurogene Inc Azioni (NGNE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi
Revenues
100.00%
-
 -2.968
Operating Expenses
40.97%
18.78
 31.82
Interest Income/Expense
0.003
 -
Operating Income/Loss
40.97%
-18.78
 -31.82
Income/Loss From Continuing Operations Before Tax
56.93%
-16.92
 -39.28
Income/Loss From Continuing Operations After Tax
9.15%
-16.92
 -15.50
Net Income/Loss
9.15%
-16.92
 -15.50
Preferred Stock Dividends And Other Adjustments
-
 -
Attributable To Noncontrolling Interest
-
 -
Basic Average Shares
16.90
 -
Diluted Average Shares
16.90
 -
Basic Earnings Per Share
-1.00
 -
Diluted Earnings Per Share
-1.00
 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
 -

Simile a NGNE

biotechnology SMMT
$17.87
price down icon 2.88%
biotechnology INCY
$68.84
price up icon 2.65%
biotechnology MRNA
$39.39
price down icon 0.43%
biotechnology UTHR
$359.58
price down icon 0.16%
biotechnology BGNE
$176.50
price up icon 1.02%
biotechnology BNTX
$113.08
price up icon 1.56%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):